Cargando…
In-hospital mortality, length of stay, and hospitalization cost of COVID-19 patients with and without hyperkalemia
BACKGROUND: Hyperkalemia (HK) may be associated with poor clinical outcomes among COVID-19 patients. This study aimed to describe the prevalence of HK and evaluate the associations between HK and in-hospital mortality, intensive care unit (ICU) admission, length of hospital stay (LOS), and hospitali...
Autores principales: | Amin, Alpesh, Moon, Rena, Agiro, Abiy, Rosenthal, Ning, Brown, Harold, Legg, Randall, Pottorf, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050185/ https://www.ncbi.nlm.nih.gov/pubmed/35490703 http://dx.doi.org/10.1016/j.amjms.2022.04.029 |
Ejemplares similares
-
Medical Costs in Patients with Hyperkalemia on Long-Term Sodium Zirconium Cyclosilicate Therapy: The RECOGNIZE II Study
por: Agiro, Abiy, et al.
Publicado: (2023) -
The Increased Clinical and Economic Burden of Hyperkalemia in Medicare Patients Admitted to Long-Term Care Settings
por: Neuenschwander, James F., et al.
Publicado: (2023) -
Impact of Sodium Zirconium Cyclosilicate Plus Renin–Angiotensin–Aldosterone System Inhibitor Therapy on Short-Term Medical Costs in Hyperkalemia: OPTIMIZE II Real-World Study
por: Dwyer, Jamie P., et al.
Publicado: (2023) -
Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis
por: Gautam, Santosh, et al.
Publicado: (2017) -
The prevalence of predialysis hyperkalemia and associated characteristics among hemodialysis patients: The RE‐UTILIZE study
por: Agiro, Abiy, et al.
Publicado: (2022)